WAKAMOTO PHARMACEUTICAL CO.,LTD. [4512.T]
TOKYO, Apr 06 (Pulse News Wire) – Wakamoto Pharmaceutical CO.,LTD. (4512.T) announced today that it plans to sell part of its investment securities portfolio, resulting in an anticipated gain from the sale of investment securities amounting to ¥152 million.
The sale is aimed at optimizing the company's asset holdings. The transaction is scheduled to take place on April 06, 2026, generating the aforementioned profit.
According to the company’s statement, this gain will be recognized as extraordinary income in the first quarter of the fiscal year ending March 2027. Looking ahead, Wakamoto expects to reflect the investment securities sale benefit of __NUM_0__ as a special item in their operating results for the first quarter of the fiscal year beginning April 2026.
🟡 Confidence: Standard AI-translated content.